Public Sector Pension Investment Board reduced its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 35.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,186 shares of the semiconductor company’s stock after selling 19,124 shares during the period. Public Sector Pension Investment Board’s holdings in Synopsys were worth $15,304,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of SNPS. BlackRock Inc. acquired a new position in Synopsys during the 2nd quarter worth approximately $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Synopsys during the 2nd quarter valued at approximately $747,400,000. Bank of New York Mellon Corp acquired a new position in Synopsys in the second quarter valued at $692,074,000. Bank of America Corp DE acquired a new stake in Synopsys during the second quarter worth approximately $539,986,000. Finally, Legal & General Group Plc bought a new stake in shares of Synopsys in the 2nd quarter valued at $491,923,000. 85.47% of the stock is currently owned by institutional investors.
Recent Synopsys Headlines
Here are a few of the latest headlines about SNPS:
- Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
- Positive Sentiment: Synopsys-backed Ansys is supporting an integration between Instem’s toxicology tools and its simulation platform, extending the company’s reach into packaging safety and materials-risk workflows. This could broaden use of its simulation ecosystem, though the financial impact is not specified. Synopsys broadens platform reach
- Negative Sentiment: A valuation analysis argues SNPS may be about 17% overvalued despite improving guidance and business performance, raising questions about whether future cash generation justifies the share price. Synopsys may be overvalued
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $396.55 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The company has a market capitalization of $76.00 billion, a PE ratio of 70.06, a PEG ratio of 1.26 and a beta of 1.18. Synopsys, Inc. has a 1-year low of $362.55 and a 1-year high of $539.48. The business has a fifty day moving average price of $448.46 and a 200-day moving average price of $440.14.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. During the same quarter in the prior year, the company posted $3.39 earnings per share. The business’s revenue for the quarter was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities analysts expect that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.
Synopsys declared that its board has approved a stock buyback plan on Monday, October 5th that permits the company to repurchase $1 billion in shares. This repurchase authorization permits the semiconductor company to buy up to 1.1% of its stock through open market purchases. Share repurchase plans are generally a sign that the company’s leadership believes its shares are undervalued.
Analysts Set New Price Targets
SNPS has been the topic of a number of research reports. Rothschild & Co Redburn lowered their target price on Synopsys from $560.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 23rd. Wells Fargo & Company lifted their price target on shares of Synopsys from $475.00 to $540.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. Weiss Ratings cut shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, September 11th. JPMorgan Chase & Co. dropped their price objective on Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. Finally, Deutsche Bank reiterated a “buy” rating and set a $640.00 price objective (up from $590.00) on shares of Synopsys in a research report on Thursday, October 1st. One analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $577.71.
Check Out Our Latest Report on SNPS
Insider Transactions at Synopsys
In other Synopsys news, insider Aart de Geus sold 24,641 shares of the stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total value of $10,335,421.04. Following the transaction, the insider owned 120,443 shares of the company’s stock, valued at approximately $50,518,611.92. This represents a 16.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Lee sold 1,144 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total transaction of $574,882.88. Following the sale, the insider owned 16,534 shares of the company’s stock, valued at $8,308,665.68. This trade represents a 6.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 117,163 shares of company stock worth $51,366,457. 0.56% of the stock is currently owned by insiders.
About Synopsys
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Further Reading
- Five stocks we like better than Synopsys
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
